| CAS ID: | 87333-19-5 |
| Molecular Formula: | C23H32N2O5 |
| Molecular Weight: | 416.5 g/mol |
| Monoisotopic Mass: | 416.2311 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | HOE 498 | RAMIPRIL | ALTACE | RANACE | TRITACE | LOPACE |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1 | See All |
| InChI Key: | HDACQVRGBOVJII-JBDAPHQKSA-N | |
| Smiles: | CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O | See All |
| Molfile: | Download |
Reference Record 1
Reference Record 2
Trial Record 1
| ClinicalTrial ID | NCT02842424 | Disease | Muscle fibrosis |
| Phase | Phase 4 | Status | Recruiting |
| First Received | July 22, 2016 | Last Verified | October 31, 2018 |
| Sponsor | University of Nebraska | ||
Trial Record 2
| ClinicalTrial ID | NCT01485978 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Active, not recruiting |
| First Received | December 6, 2011 | Last Verified | October 25, 2017 |
| Sponsor | Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | ||
| PubChem: | 6992028 |
| ChEMBL: | CHEMBL1168 |